carbamates has been researched along with laromustine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Buros, CM; Gerber, SA; Klinkerch, EJ; Kraus, TJ; Rice, KP; Schleicher, TR | 1 |
Cincotta, DJ; Ghazvinian, R; He, Y; Ji, W; Li, Y; Min, W; Praggastis, A; Rice, KP; Yang, M; Zhou, HJ | 1 |
2 other study(ies) available for carbamates and laromustine
Article | Year |
---|---|
Thioredoxin reductase is inhibited by the carbamoylating activity of the anticancer sulfonylhydrazine drug laromustine.
Topics: Amino Acid Sequence; Animals; Antineoplastic Agents; Carbamates; Carmustine; Cell Line, Tumor; Cysteine; Drug Screening Assays, Antitumor; Hydrazines; Hydrogen-Ion Concentration; Isocyanates; Mice; Molecular Sequence Data; Peptides; Rats; Sulfonamides; Tandem Mass Spectrometry; Thioredoxin-Disulfide Reductase; Time Factors | 2012 |
Carbamoylating activity associated with the activation of the antitumor agent laromustine inhibits angiogenesis by inducing ASK1-dependent endothelial cell death.
Topics: Animals; Antineoplastic Agents; Biocatalysis; Carbamates; Cattle; Cell Death; Cells, Cultured; Endothelial Cells; Humans; Hydrazines; Immunoblotting; Isocyanates; MAP Kinase Kinase Kinase 5; Mitogen-Activated Protein Kinase 8; Neovascularization, Physiologic; Signal Transduction; Sulfonamides; Thioredoxin Reductase 1; Thioredoxins | 2014 |